SARS‑COV‑2
TREATMENTS
REMDESIVIR
CONVALESCENT PLASMA
DEXAMETHASONE
U.S Food & Drug Administration approved treatment for COVID-19. Shown to significantly reduce recovery time in patients when combined with acute hospital or facility care. Antiviral agent that accelerates COVID-19 recovery.
High titer COVID-19 convalescent plasma units shown to contain antibodies to SARS-CoV-2 have proven to show benefits if administered early. Granted emergency use of authorization (EUA) by U.S Food & Drug Administration to treat life threatening case.
Corticosteroid used as an anti-inflammatory and immunosuppressant. World Health Organization reports reductions in mortality by about one third for patients on ventilators, and for patients requiring only oxygen, by about one fifth. Useful for combatting hyperinflammation of respiratory tract and cytokine storm.